Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 6, 2006, Pages 1248-1250

  den Hollander, Jan G ^a,b   van Arkel, Cornelis ^b   Rijnders, Bart J ^b   Lugtenburg, Pieternella J ^b   de Marie, Siem ^b   Levin, Mark David ^b,c  

^a Kinderafdeling   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

Haematological disease; Invasive aspergillosis; Therapy

Indexed keywords

CIPROFLOXACIN; CYCLOSPORIN; FUROSEMIDE; IMIPENEM; ITRACONAZOLE; LIVER ENZYME; METOCLOPRAMIDE; OMEPRAZOLE; PENICILLIN G; PREDNISONE; TEMAZEPAM; VALACICLOVIR; VANCOMYCIN; VORICONAZOLE; ANTIFUNGAL AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG METABOLISM; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; LIVER TOXICITY; MYCOSIS; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SECONDARY PREVENTION; TREATMENT DURATION; COMPARATIVE STUDY; DRUG EFFECT; HEMATOLOGIC DISEASE; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER FUNCTION TEST; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; HEMATOLOGIC DISEASES; HUMANS; INJECTIONS, INTRAVENOUS; LIVER; LIVER FUNCTION TESTS; MYCOSES; PYRIMIDINES; RETROSPECTIVE STUDIES; TRIAZOLES;

EID: 33749166513     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl108     Document Type: Article

References (6)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-803.
2. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-15.
3. Potoski BA, Brown J. The safety of voriconazole. Clin Infect Dis 2002; 35: 1273-5.
4. Becker MJ, Lugtenburg EJ, Cornelissen JJ et al. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 2003; 121: 448-57.
5. Denning DW, Ribaud P, Milpied N et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002; 34: 563-71.
6. Lutsar I, Hedges MR, Tomaszewski K et al. Safety of voriconazole and dose individualization. Clin Infect Dis 2003; 36: 1087-8.